Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC), 59626 [2016-20760]
Download as PDF
<![CDATA[
59626
Federal Register / Vol. 81, No. 168 / Tuesday, August 30, 2016 / Notices
Category 2 of the FPL and/or to support
other activities not currently under
consideration by the Council. As
appropriate, the Council intends to
review each activity in Category 2 in
order to determine whether to: (1) Move
the activity to Category 1 and approve
it for funding, (2) remove it from
Category 2 and any further
consideration, or (3) continue to include
it in Category 2. A Council decision to
amend the FPL to move an activity from
Category 2 into Category 1 must be
approved by a Council vote after
consideration of public and Tribal
comments.
mstockstill on DSK3G9T082PROD with NOTICES
II. Environmental Compliance
Prior to approving an activity for
funding in FPL Category 1, the Council
must comply with NEPA and other
Federal environmental laws. At the time
of approval of the FPL, the Council had
not complied with NEPA and other
applicable laws with respect to
implementation of the Project. The
Council did, however, recognize the
potential ecological value of the Project,
based on review conducted as part of
the FPL process. For this reason, the
Council approved $702,000 in planning
funds for this Project, a portion of which
would be used to complete any needed
environmental compliance activities. As
noted above, the Council placed the
implementation portion of this Project
into FPL Category 2, pending the
outcome of this environmental
compliance work and further Council
review. The estimated cost of the
Project’s implementation component
was listed at $3,978,000, which would
fund the restoration of approximately
219 acres of oyster beds in Apalachicola
Bay. Inclusion of the Project’s
implementation activities into Category
2 did not in any way commit the
Council to subsequently approve those
implementation activities for funding.
Since approval of the FPL, Florida has
collaborated with the U.S. Army Corps
of Engineers (USACE) and identified an
existing EA that could be used to
support Council approval of
implementation funding for this Project.
This EA was prepared by the USACE in
association with a Clean Water Act
Section 404 and Section 10 of the Rivers
and Harbors Act programmatic general
permit (PGP). This PGP authorizes the
Florida Department of Agricultural and
Consumer Services to conduct
aquaculture of live rock and marine
bivalves in navigable waters of the U.S.
within the jurisdiction of the State of
Florida, provided that such activities
comply with the terms and conditions
of the PGP.
VerDate Sep<11>2014
20:04 Aug 29, 2016
Jkt 238001
The Council has reviewed this EA and
associated documents, including an
August 13, 2015, letter from the
National Oceanic and Atmospheric
Administration regarding compliance
with the Endangered Species Act (ESA).
In addition to ESA, the EA and
associated PGP address compliance
with other Federal environmental laws,
including the Magnuson-Stevens
Fishery Conservation and Management
Act, the National Historic Preservation
Act and more.
On June 7, 2016, the Council issued
a Federal Register notice announcing its
proposal to amend the FPL, adopt the
aforementioned EA, and approve
implementation funding for this Project.
The Council received no public
comments on this proposal.
Based on this review, the Council
adopted this EA to support the approval
of implementation funds for the Project,
based on the condition that the Project
must be implemented in accordance
with the terms and conditions of the
PGP and the design criteria set forth in
the associated ESA programmatic
consultation. Strict adherence with the
terms and conditions of the PGP is
necessary to ensure compliance ESA
and other applicable laws. On August
24, 2016, the Council issued a Finding
of No Significant Impact (FONSI) for
this action, concurrent with its approval
of the FPL amendment. This EA, FONSI,
and the associated ESA documentation
can be found here: https://
www.restorethegulf.gov/fundedpriorities-list. (See Apalachicola Bay
Oyster Restoration Project—
Implementation.)
Additional information on the Project
is available in an activity-specific
appendix to the FPL, which can be
found here: https://
www.restorethegulf.gov.
Justin R. Ehrenwerth,
Executive Director, Gulf Coast Ecosystem
Restoration Council.
[FR Doc. 2016–20743 Filed 8–29–16; 8:45 am]
BILLING CODE 6560–58–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Time and Date: 8:30 a.m.–3:00 p.m., EDT,
October 20, 2016.
Place: CDC, Building 21, Executive Board
Room (12105) and Room 12302, 1600 Clifton
Road NE., Atlanta, Georgia 30329.
Status: Open to the public, limited only by
the space and phone lines available. The
meeting rooms accommodate approximately
65 people. Advance registration for in-person
participation is required by October 6, 2016.
The public is welcome to participate during
the public comment period, which is
tentatively scheduled from 2:40 p.m. to 2:45
p.m. This meeting will also be available by
teleconference. Please dial (888) 324–9970
and enter code 32077657.
Purpose: The Advisory Committee to the
Director, CDC, shall advise the Secretary,
HHS, and the Director, CDC, on policy and
broad strategies that will enable CDC to fulfill
its mission of protecting health through
health promotion, prevention, and
preparedness. The committee recommends
ways to prioritize CDC’s activities, improve
results, and address health disparities. It also
provides guidance to help CDC work more
effectively with its various private and public
sector constituents to make health protection
a practical reality.
Matters for Discussion: The Advisory
Committee to the Director will receive
updates from the State, Tribal, Local and
Territorial Subcommittee; the Health
Disparities Subcommittee, the Global
Workgroup, and the Public Health—Health
Care Collaboration Workgroup, as well as an
update from the CDC Director.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Carmen Villar, MSW, Designated Federal
Officer, ACD, CDC, 1600 Clifton Road NE.,
M/S D–14, Atlanta, Georgia 30329.
Telephone (404) 498–6482, Email:
ACDirector@cdc.gov. The deadline to register
for in-person attendance at this meeting is
October 6, 2016. To register, please send an
email to ACDirector@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention (CDC).
[FR Doc. 2016–20760 Filed 8–29–16; 8:45 am]
BILLING CODE 4163–18–P
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
PO 00000
Frm 00030
Fmt 4703
Sfmt 9990
E:\FR\FM\30AUN1.SGM
30AUN1
]]>Agencies
[Federal Register Volume 81, Number 168 (Tuesday, August 30, 2016)]
[Notices]
[Page 59626]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-20760]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention (CDC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee:
Time and Date: 8:30 a.m.-3:00 p.m., EDT, October 20, 2016.
Place: CDC, Building 21, Executive Board Room (12105) and Room
12302, 1600 Clifton Road NE., Atlanta, Georgia 30329.
Status: Open to the public, limited only by the space and phone
lines available. The meeting rooms accommodate approximately 65
people. Advance registration for in-person participation is required
by October 6, 2016. The public is welcome to participate during the
public comment period, which is tentatively scheduled from 2:40 p.m.
to 2:45 p.m. This meeting will also be available by teleconference.
Please dial (888) 324-9970 and enter code 32077657.
Purpose: The Advisory Committee to the Director, CDC, shall
advise the Secretary, HHS, and the Director, CDC, on policy and
broad strategies that will enable CDC to fulfill its mission of
protecting health through health promotion, prevention, and
preparedness. The committee recommends ways to prioritize CDC's
activities, improve results, and address health disparities. It also
provides guidance to help CDC work more effectively with its various
private and public sector constituents to make health protection a
practical reality.
Matters for Discussion: The Advisory Committee to the Director
will receive updates from the State, Tribal, Local and Territorial
Subcommittee; the Health Disparities Subcommittee, the Global
Workgroup, and the Public Health--Health Care Collaboration
Workgroup, as well as an update from the CDC Director.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Carmen Villar, MSW,
Designated Federal Officer, ACD, CDC, 1600 Clifton Road NE., M/S D-
14, Atlanta, Georgia 30329. Telephone (404) 498-6482, Email:
ACDirector@cdc.gov. The deadline to register for in-person
attendance at this meeting is October 6, 2016. To register, please
send an email to ACDirector@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 2016-20760 Filed 8-29-16; 8:45 am]
BILLING CODE 4163-18-P
